CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, February 24, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

Only treatment approved in the US for relapsed or refractory hairy cell leukemia Approved by FDA at ASH 2019

admin - 0
Latest Pharma-News

Amgen’s AVSOLA™ received FDA approval for AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab)for the treatment of Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis,...

admin - 0
Latest Pharma-News

ViiV Healthcare submits New Drug Application to the US FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults

admin - 0
Latest Pharma-News

FDA authorizes marketing of diagnostic test cobas vivoDx that uses novel technology to detect Methicillin-resistant Staphylococcus aureus (MRSA) bacteria

admin - 0
Latest Pharma-News

First investigational drug therapy for liver disease non alcoholic steatohepatitis (NASH) awaiting FDA approval

admin - 0
Latest Pharma-News

Data fron XOSPATA® in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual Meeting

admin - 0
Latest Pharma-News

First generics of Gilenya approved by FDA for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients

admin - 0
Latest Pharma-News

U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Alecto’s investigational therapeutic AL001, for the treatment of patients with...

admin - 0
Latest Pharma-News

U.S. FDA approved BMS Breakthrough Therapy Designation for ORENCIA® (abatacept) just to help in Preventing Acute Graft-Versus-Host Disease, a Potentially Life-Threatening Complication...

admin - 0
Latest Pharma-News

U.S. Food and Drug Administration (FDA) approved Investigational New Drug (IND) application for Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy

admin - 0
Latest Pharma-News

Ardelyx’s kidney disease drug succeeded in regulating elevated blood phosphate levels in patients with chronic kidney disease (CKD)

admin - 0
Latest Pharma-News

United States Food and Drug Administration (USFDA) approved Bortezomib for Injection (IV) 3.5 mg/vial for the treatment of cancers in adult patients

admin - 0
1...138139140...145Page 139 of 145
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved